172 related articles for article (PubMed ID: 35098746)
21. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R
J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924
[TBL] [Abstract][Full Text] [Related]
22. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
[TBL] [Abstract][Full Text] [Related]
23. Do Restrictions on Antipsychotic Use Differ Between Medicare Part D Stand-Alone Versus Medicare Advantage Plans?
Chou J; Brandt NJ; Loh FE; Stuart B
Consult Pharm; 2017 Feb; 32(2):109-118. PubMed ID: 28569663
[TBL] [Abstract][Full Text] [Related]
24. Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017.
Zhu J; Alexander GC; Nazarian S; Segal JB; Wu AW
Pharmacotherapy; 2018 Sep; 38(9):907-920. PubMed ID: 29920705
[TBL] [Abstract][Full Text] [Related]
25. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
Mhatre SK; Serna O; Sansgiry S; Fleming ML; Essien EJ; Sansgiry SS
J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
[TBL] [Abstract][Full Text] [Related]
26. Is There a Relationship Between Part D Medication Adherence and Part C Intermediate Outcomes Star Ratings Measures?
Ta JT; Erickson SC; Qiu WA; Patel BV
J Manag Care Spec Pharm; 2016 Jul; 22(7):787-95. PubMed ID: 27348279
[TBL] [Abstract][Full Text] [Related]
27. Evaluating Success Factors of a Medication Adherence Tracker Pilot Program in Improving Part D Medication Adherence Metrics in a Medicare Advantage Plan: Importance of Provider Engagement.
Hong M; Esse T; Vadhariya A; Gallardo E; Fosshat MA; Mamvou J; Bruce L; Serna O; Abughosh S
J Manag Care Spec Pharm; 2020 May; 26(5):662-667. PubMed ID: 32347173
[TBL] [Abstract][Full Text] [Related]
28. Medicare Part D: early findings on enrollment and choices for rural beneficiaries.
McBride TD; Terry TL; Mueller KJ
Rural Policy Brief; 2006 Apr; 10(8 (PB2006-8)):1-9. PubMed ID: 16685809
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
Perera PN; Guy MC; Sweaney AM; Boesen KP
J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
Leslie RS; Tirado B; Patel BV; Rein PJ
J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
[TBL] [Abstract][Full Text] [Related]
31. Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence.
Abughosh SM; Vadhariya A; Johnson ML; Essien EJ; Esse TW; Serna O; Gallardo E; Boklage SH; Choi J; Holstad MM; Fleming ML
J Manag Care Spec Pharm; 2019 Oct; 25(10):1053-1062. PubMed ID: 31556824
[TBL] [Abstract][Full Text] [Related]
32. Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications.
Kefale AT; Bezabhe WM; Peterson GM
J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834830
[TBL] [Abstract][Full Text] [Related]
33. Medicare program; Medicare prescription drug benefit. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
[TBL] [Abstract][Full Text] [Related]
34. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
[TBL] [Abstract][Full Text] [Related]
35. Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease.
Briasoulis A; Inampudi C; Akintoye E; Alvarez P; Panaich S; Vaughan-Sarrazin M
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29622591
[TBL] [Abstract][Full Text] [Related]
36. Drug plan design incentives among Medicare prescription drug plans.
Huskamp HA; Keating NL; Dalton JB; Chernew ME; Newhouse JP
Am J Manag Care; 2014 Jul; 20(7):562. PubMed ID: 25295402
[TBL] [Abstract][Full Text] [Related]
37. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
38. Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation.
Alalwan AA; Voils SA; Hartzema AG
Am J Health Syst Pharm; 2017 Aug; 74(16):1237-1244. PubMed ID: 28652320
[TBL] [Abstract][Full Text] [Related]
39. Association of Healthcare Plan with atrial fibrillation prescription patterns.
Chang AY; Askari M; Fan J; Heidenreich PA; Michael Ho P; Mahaffey KW; Ullal AJ; Perino AC; Turakhia MP
Clin Cardiol; 2018 Sep; 41(9):1136-1143. PubMed ID: 30098034
[TBL] [Abstract][Full Text] [Related]
40. A retrospective cohort study of oral anticoagulant treatment in patients with acute coronary syndrome and atrial fibrillation.
Mai L; Wu Y; Luo J; Liu X; Zhu H; Zheng H; Liang G; Zhang Y; Huang Y
BMJ Open; 2019 Sep; 9(9):e031180. PubMed ID: 31530618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]